In this clinical/observational study we have reported the administration of Palmitoylethanolamide (PEA) in patients suffering from radicular lumbar spinal pathology, who had no indication for surgical treatment. We analyzed a series of 100 cases retrospectively, all undergoing clinical and diagnostic investigations, which had shown the presence of abnormalities of the vertebral body and intervertebral discs, mainly degenerative, such as spondyloarthrosis, spondylo-discarthrosis, disc protrusion, excluding disc herniation, which fell within surgical cases. We then administered ultramicronized PEA (umPEA) to these patients, in combination with paracetamol and codeine, obtaining interesting results regarding the improvement of pain symptoms of...
Palmitoylethanolamide (PEA) stands out among endogenous lipid mediators for its neuroprotective, an...
Disclosure and conflict of interest: The authors declare no conflict of interest and no disclosure o...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication of antineoplastic drugs, ...
In this clinical/observational study we have reported the administration of Palmitoylethanolamide (P...
In this clinical/observational study we have reported the administration of Palmitoylethanolamide (P...
Neuropathic pain and spasticity after spinal cord injury (SCI) represent significant problems. Palmi...
Background: This pilot study was designed to compare the efficacy of ultramicronized palmitoylethano...
Chronic low ba,:k pain (LBP) caused by intervertebral disc herniation was reported in the 2010 Globa...
Some 30-50% of the global population and almost 20% of the European population actually suffer from ...
Background: Neuropathic pain is defined by International Association for the Study of Pain (IASP) as...
Jan M Keppel Hesselink, David J Kopsky Institute for Neuropathic Pain, Bosch en Duin, the Nethe...
Abstract Background This pilot study was designed to compare the efficacy of ultramicronized palmito...
Palmitoylethanolamide (PEA) is an endogenous lipid mediator known to reduce pain and inflammation. H...
Background: Ultra-micronized palmitoylethanolamide (um-PEA) represents an attractive option for chro...
Palmitoylethanolamide (PEA) is a pleiotropic lipid mediator with established anti-inflammatory and a...
Palmitoylethanolamide (PEA) stands out among endogenous lipid mediators for its neuroprotective, an...
Disclosure and conflict of interest: The authors declare no conflict of interest and no disclosure o...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication of antineoplastic drugs, ...
In this clinical/observational study we have reported the administration of Palmitoylethanolamide (P...
In this clinical/observational study we have reported the administration of Palmitoylethanolamide (P...
Neuropathic pain and spasticity after spinal cord injury (SCI) represent significant problems. Palmi...
Background: This pilot study was designed to compare the efficacy of ultramicronized palmitoylethano...
Chronic low ba,:k pain (LBP) caused by intervertebral disc herniation was reported in the 2010 Globa...
Some 30-50% of the global population and almost 20% of the European population actually suffer from ...
Background: Neuropathic pain is defined by International Association for the Study of Pain (IASP) as...
Jan M Keppel Hesselink, David J Kopsky Institute for Neuropathic Pain, Bosch en Duin, the Nethe...
Abstract Background This pilot study was designed to compare the efficacy of ultramicronized palmito...
Palmitoylethanolamide (PEA) is an endogenous lipid mediator known to reduce pain and inflammation. H...
Background: Ultra-micronized palmitoylethanolamide (um-PEA) represents an attractive option for chro...
Palmitoylethanolamide (PEA) is a pleiotropic lipid mediator with established anti-inflammatory and a...
Palmitoylethanolamide (PEA) stands out among endogenous lipid mediators for its neuroprotective, an...
Disclosure and conflict of interest: The authors declare no conflict of interest and no disclosure o...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication of antineoplastic drugs, ...